rs564402674

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_001387283.1(SMARCA4):​c.2617-110G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00348 in 1,371,434 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as not provided (no stars).

Frequency

Genomes: 𝑓 0.0019 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0037 ( 14 hom. )

Consequence

SMARCA4
NM_001387283.1 intron

Scores

2

Clinical Significance

not provided no classification provided O:1

Conservation

PhyloP100: -0.111

Publications

1 publications found
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
  • intellectual disability, autosomal dominant 16
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rhabdoid tumor predisposition syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • uterine corpus sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00193 (294/152316) while in subpopulation NFE AF = 0.00334 (227/68022). AF 95% confidence interval is 0.00298. There are 0 homozygotes in GnomAd4. There are 145 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 14 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCA4NM_001387283.1 linkc.2617-110G>A intron_variant Intron 18 of 35 ENST00000646693.2 NP_001374212.1
SMARCA4NM_003072.5 linkc.2617-110G>A intron_variant Intron 18 of 34 ENST00000344626.10 NP_003063.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCA4ENST00000646693.2 linkc.2617-110G>A intron_variant Intron 18 of 35 NM_001387283.1 ENSP00000495368.1
SMARCA4ENST00000344626.10 linkc.2617-110G>A intron_variant Intron 18 of 34 1 NM_003072.5 ENSP00000343896.4
SMARCA4ENST00000643549.1 linkc.2617-110G>A intron_variant Intron 18 of 34 ENSP00000493975.1
SMARCA4ENST00000541122.6 linkc.2617-110G>A intron_variant Intron 19 of 34 5 ENSP00000445036.2
SMARCA4ENST00000643296.1 linkc.2617-110G>A intron_variant Intron 18 of 33 ENSP00000496635.1
SMARCA4ENST00000644737.1 linkc.2617-110G>A intron_variant Intron 18 of 33 ENSP00000495548.1
SMARCA4ENST00000589677.5 linkc.2617-110G>A intron_variant Intron 19 of 34 5 ENSP00000464778.1
SMARCA4ENST00000643995.1 linkc.2029-110G>A intron_variant Intron 15 of 31 ENSP00000496004.1
SMARCA4ENST00000644963.1 linkc.1261-110G>A intron_variant Intron 11 of 27 ENSP00000495599.1
SMARCA4ENST00000644065.1 linkc.1342-110G>A intron_variant Intron 11 of 26 ENSP00000493615.1
SMARCA4ENST00000642350.1 linkc.1102-110G>A intron_variant Intron 10 of 26 ENSP00000495355.1
SMARCA4ENST00000643857.1 linkc.970-110G>A intron_variant Intron 9 of 24 ENSP00000494159.1

Frequencies

GnomAD3 genomes
AF:
0.00193
AC:
294
AN:
152198
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000700
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00170
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00334
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00209
AC:
296
AN:
141710
AF XY:
0.00191
show subpopulations
Gnomad AFR exome
AF:
0.000935
Gnomad AMR exome
AF:
0.00170
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000133
Gnomad NFE exome
AF:
0.00388
Gnomad OTH exome
AF:
0.00117
GnomAD4 exome
AF:
0.00367
AC:
4477
AN:
1219118
Hom.:
14
Cov.:
18
AF XY:
0.00358
AC XY:
2183
AN XY:
609694
show subpopulations
African (AFR)
AF:
0.000672
AC:
19
AN:
28258
American (AMR)
AF:
0.00161
AC:
57
AN:
35490
Ashkenazi Jewish (ASJ)
AF:
0.0000415
AC:
1
AN:
24098
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34916
South Asian (SAS)
AF:
0.000839
AC:
63
AN:
75104
European-Finnish (FIN)
AF:
0.000215
AC:
8
AN:
37268
Middle Eastern (MID)
AF:
0.000370
AC:
2
AN:
5402
European-Non Finnish (NFE)
AF:
0.00452
AC:
4183
AN:
926244
Other (OTH)
AF:
0.00275
AC:
144
AN:
52338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
227
454
682
909
1136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
160
320
480
640
800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00193
AC:
294
AN:
152316
Hom.:
0
Cov.:
33
AF XY:
0.00195
AC XY:
145
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.000697
AC:
29
AN:
41578
American (AMR)
AF:
0.00170
AC:
26
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4824
European-Finnish (FIN)
AF:
0.000377
AC:
4
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00334
AC:
227
AN:
68022
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
13
26
40
53
66
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00251
Hom.:
1
Bravo
AF:
0.00193
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: not provided
Submissions summary: Other:1
Revision: no classification provided
LINK: link

Submissions by phenotype

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
3.1
DANN
Benign
0.85
PhyloP100
-0.11
PromoterAI
-0.028
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs564402674; hg19: chr19-11132291; COSMIC: COSV106477823; API